Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Net Cash Flow (2024 - 2025)

Historic Net Cash Flow for Kestra Medical Technologies (KMTS) over the last 2 years, with Q4 2025 value amounting to -$25.8 million.

  • Kestra Medical Technologies' Net Cash Flow fell 1188.23% to -$25.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $98.5 million, marking a year-over-year increase of 5940.0%. This contributed to the annual value of $229.3 million for FY2025, which is 350326.46% up from last year.
  • Per Kestra Medical Technologies' latest filing, its Net Cash Flow stood at -$25.8 million for Q4 2025, which was down 1188.23% from -$36.4 million recorded in Q3 2025.
  • Kestra Medical Technologies' 5-year Net Cash Flow high stood at $183.2 million for Q2 2025, and its period low was -$36.4 million during Q3 2025.